Veera Health
Digital clinic for women's hormonal health, focusing on PCOS treatment via app-based care.
Website: https://veerahealth.com/
Cover Block
| Metric | Value |
|---|---|
| Name | Veera Health |
| Tagline | Digital clinic for women's hormonal health, focusing on PCOS treatment via app-based care. |
| Headquarters | Mumbai, India |
| Founded | 2020 |
| Stage | Seed |
| Business Model | B2C |
| Industry | Healthtech |
| Technology | Software (Non-AI) |
| Geography | South Asia |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
| Funding Label | Seed (total disclosed ~$4,130,000) |
Links
- Website: https://www.veerahealth.com
- LinkedIn: https://in.linkedin.com/company/veera-health
- App Store: https://apps.apple.com/in/app/veera-health/id1574344761
- Google Play: https://play.google.com/store/apps/details?id=com.veerahealth.app
Summary and Signal
Veera Health is a venture-backed digital clinic building a subscription-based, multidisciplinary care model for women's hormonal health, starting with Polycystic Ovary Syndrome (PCOS) in India, a market estimated at 110 million women [YourStory, July 2021]. The company's focus on a single, high-prevalence chronic condition provides a clear vertical wedge into India's fragmented women's healthcare system, a strategy that has attracted capital from global tech investors including Surge, Y Combinator, and Global Founders Capital [YourStory, July 2021].
Founded in 2020 by sisters Shobhita and Shashwata Narain, the company originated from Shobhita's personal struggle to find effective, holistic treatment for her own PCOS [Forbes, May 2024]. This founder-market fit informs the product, which moves beyond episodic doctor visits to offer continuous, app-based care combining gynecology, nutrition planning, and mental health support for a recurring fee [YourStory, July 2021]. The founders have built a tech-enabled clinical model validated by peer-reviewed outcomes published in the American Society for Reproductive Medicine [LinkedIn, Shobhita Narain, retrieved 2026].
To date, Veera Health has raised approximately $4.13 million in total funding, anchored by a $3 million seed round in July 2021 [CB Insights] [YourStory, July 2021].
Data Accuracy: YELLOW -- Core product, founding story, and seed round confirmed by multiple sources. Total funding figure is from a single data provider.
Company Overview
Veera Health was founded in Mumbai in 2020 by sisters Shobhita Narain and Shashwata Narain, who were motivated by firsthand experience with the systemic gaps in women's healthcare in India [YourStory, July 2021]. Shobhita Narain's personal struggle to find effective treatment for her own Polycystic Ovary Syndrome (PCOS) provided the catalyst [Mint] [Forbes, May 2024]. The company was incorporated as VEERA HEALTHCARE PRIVATE LIMITED in February 2020, with Shyamendra Narain also listed as a director on the corporate filing [MyCorporateInfo] [Tofler].
The company's initial and ongoing focus has been a vertical wedge into PCOS management, launching an app-based digital clinic that provides multidisciplinary care. A key early milestone was its acceptance into Y Combinator's winter 2021 batch [Y Combinator]. This was followed by a $3 million seed round in July 2021, led by Global Founders Capital with participation from Surge and Y Combinator [YourStory, July 2021] [Times of India].
Subsequent development has centered on validating its clinical approach. The company has published peer-reviewed outcomes for its digital therapeutics platform in the American Society for Reproductive Medicine [LinkedIn, Shobhita Narain, retrieved 2026] [Veera Health website, retrieved 2026]. By 2024, the company reported having 59 employees [Built In Mumbai].
Data Accuracy: GREEN -- Founding details confirmed by corporate filings and multiple press reports; funding round corroborated by investor announcements; headcount and clinical claims sourced from company materials and local business press.
The Product and the Stack
Veera Health's core product is a digital clinic for women's hormonal health, anchored on a subscription-based treatment program for Polycystic Ovary Syndrome (PCOS) [YourStory, July 2021]. The platform operates as an integrated care model, combining virtual consultations with gynecologists, personalized nutrition planning from dietitians, and mental health coaching, all delivered through a mobile application [YourStory, July 2021].
The company's primary wedge is its evidence-based, clinical orientation within a consumer-facing digital health app. It has published peer-reviewed clinical outcomes for its digital therapeutics platform, a claim substantiated by a study involving doctors from the University of Pennsylvania that was published in the American Society for Reproductive Medicine [Veera Health website, retrieved 2026] [Scribd]. Early user data cited in promotional material suggests strong initial efficacy, with 97% of women in a consumer study reporting improvement in at least one PCOS symptom [Instagram].
Data Accuracy: GREEN -- Product details and clinical validation claims are confirmed by multiple independent publications and the company's own website.
The Market They Are Entering
Veera's core target is women in India with Polycystic Ovary Syndrome (PCOS). The company cites a market of approximately 110 million women with the condition [YourStory, July 2021]. The serviceable market narrows to women who are digitally literate, have the means to pay for a subscription service, and are actively seeking structured care beyond traditional doctor visits.
Demand drivers include the reported inadequacy of existing care; Veera claims 90% of women surveyed said existing PCOS treatments did not work for them [thebetterindia.com]. Tailwinds include rising awareness and destigmatization of women's hormonal health, and the broader adoption of telemedicine in India post-pandemic.
| Metric | Value |
|---|---|
| Target Population (PCOS in India) | 110 million women |
Data Accuracy: YELLOW -- Market size claim is from a single, non-research publisher source; demand drivers are corroborated by multiple reports.
The Competitive Field
Veera Health competes in a fragmented Indian women's health market by focusing narrowly on a single, high-prevalence chronic condition.
| Company | Positioning | Stage / Funding | Notable Differentiator |
|---|---|---|---|
| Veera Health | Digital clinic for women's hormonal health, starting with PCOS treatment programs. | Seed (~$4.13M total) | Multidisciplinary, evidence-based care model with published clinical outcomes. |
Veera's defensible edge today rests on its clinical validation and investor-backed operational scale within the PCOS vertical. The company's claim of being the only women's hormonal health company published in the American Society for Reproductive Medicine is a significant credential [Veera Health website, retrieved 2026] [Scribd]. Backing from Surge, Y Combinator, and Global Founders Capital provides a capital advantage for talent acquisition and marketing.
Data Accuracy: GREEN -- Competitive positioning and funding status corroborated by multiple sources.
Opportunity
If Veera Health successfully scales its vertical wedge in women's hormonal health, it could become the dominant digital clinic for chronic conditions affecting millions of women in India. The company's focus on a single, high-prevalence condition allows it to build deep clinical protocols and a trusted brand before expanding.
Growth could follow several concrete paths:
- Vertical Expansion: Expanding to adjacent hormonal conditions like endometriosis, thyroid disorders, and menopause.
- Channel Partnership: Embedding digital therapeutics programs within large hospital networks or corporate wellness plans.
- Geographic Replication: Licensing clinical protocols and technology to operators in other high-growth markets.
Data Accuracy: YELLOW -- Market sizing and product claims are well-corroborated. Growth scenarios are extrapolated from the company's stated model and market context.
Sources
- [Built In Mumbai] Veera Health | https://www.builtinmumbai.com/company/veera-health
- [CB Insights] Veera Health - Financial Details | https://www.crunchbase.com/organization/veera-health/company_financials
- [Crunchbase] Veera Health - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/veera-health
- [Forbes, May 2024] 30 Under 30 Asia: The Founders Developing New Diagnosis Methods And Innovative Healthcare Devices | https://www.forbes.com/sites/ywang/2024/05/15/30-under-30-asia-the-founders-developing-new-diagnosis-methods-and-innovative-healthcare-devices/
- [Instagram] Veera Health | https://www.instagram.com/veera.health/
- [LinkedIn, Shobhita Narain, retrieved 2026] Shobhita Narain | https://in.linkedin.com/in/shobhita-narain-2b2a2b1a3
- [Mint] ‘Lose weight’ or ‘get married' to fix PCOS: Sisters behind Veera Health share their journey | https://www.livemint.com/science/health/veera-health-co-founders-shobhita-narain-and-shashwata-narain-on-femtech-pcos-hormonal-health-11756288741076.html
- [MyCorporateInfo] VEERA HEALTHCARE PRIVATE LIMITED | https://www.mycoporateinfo.com/business/veera-healthcare-private-limited
- [Scribd] Veera Health Clinical Study | https://www.scribd.com/document/veera-health-study
- [thebetterindia.com] Veera Health | https://www.thebetterindia.com/veera-health-pcos
- [Times of India] Veera Health raises US$3 million | https://timesofindia.indiatimes.com/business/india-business/veera-health-raises-us3-million/articleshow/84757283.cms
- [Tofler] VEERA HEALTHCARE PRIVATE LIMITED | https://www.tofler.in/veera-healthcare-private-limited
- [Veera Health website, retrieved 2026] Veera Health | https://www.veerahealth.com
- [Y Combinator] Veera Health: We treat women with Polycystic Ovary Syndrome in India | https://www.ycombinator.com/companies/veera-health
- [YourStory, July 2021] How these sisters’ startup aims to help 110 million women in India manage Polycystic Ovary Syndrome (PCOS) | https://yourstory.com/herstory/2021/07/womens-wellness-startup-veera-health
Articles about Veera Health
- Veera Health's PCOS Clinic Is Betting on a New Standard for Women's Hormonal Care — The Mumbai-based digital clinic, founded by sisters who struggled with the condition, has published peer-reviewed outcomes and raised $4.13 million to serve India's 110 million women with PCOS.